Progressive alliance advances science through patient-powered research - Insights
Tying together the expertise and curiosity of Mayo Clinic autoimmune neurology researchers with eager patients who have rare disease and are looking for answers, the innovative collaboration benefits both patients affected by MOGAD and...
Synthesizing cardiovascular genetic test results into a unified diagnosis for the patient - Insights
For over two decades, Mayo Clinic has been at the forefront of cardiovascular (CV) genetic testing. The current test menu features 24 different panels that span over 300 genes linked to inherited cardiovascular disorders, many of which are...
Reclaiming strength and independence after rare cancer diagnosis: Alexa Lofaro - Insights
It’s been more than three years since a team of specialists and genetic testing by Mayo Clinic Laboratories helped pinpoint the cause of Alexa Lofaro’s failing health. And today, she says she continues to feel “so much better” than she did...
New AI-augmented test refines kidney stone analysis - Insights
Since March 2019, Paul Jannetto, Ph.D., director of the Metals Laboratory at Mayo Clinic, along with his colleagues across the enterprise and his laboratory staff, have developed, validated, and implemented an artificial intelligence...
Regaining quality of life after a decade lost to misdiagnosis: Kelly Dubois - Insights
Misdiagnosed with acromegaly, a disease marked by too much growth hormone, and plagued by a host of mysterious health problems from unnecessary medications, Kelly DuBois finally found answers after pharmacogenomic testing from Mayo Clinic...
Diagnostic expertise leads to recovery from rare cancer: Alison O'Neill - Insights
After what looked like a blemish turned out to be angiosarcoma, a rare, life-threatening cancer of the blood vessels, Alison O'Neill was put on an aggressive treatment plan and regenerative approach to healing made possible by the...
Optional MFA for Mayo Clinic Laboratories applications coming soon - Insights
Mayo Clinic Laboratories is committed to security and to protecting your information. As part of this commitment, we will implement an optional two-step login process for Mayo Clinic Laboratories applications called Multi-Factor...
Next-generation sequencing lung cancer panel identifies more genetic abnormalities - Insights
Mayo Clinic Laboratories’ new MayoComplete Lung Cancer Panel (Mayo ID: MCLNG) provides more information than single-gene assays and faster results than a comprehensive solid tumor panel that covers hundreds of genes.
Facebook Email or phone Password...
Facebook Email or phone Password...